These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17206108)

  • 1. Biomarkers trump behavior in mental illness diagnosis.
    Haag AL
    Nat Med; 2007 Jan; 13(1):3. PubMed ID: 17206108
    [No Abstract]   [Full Text] [Related]  

  • 2. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
    Gabelle A; Roche S; Lehmann S
    Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.
    Simonsen AH; McGuire J; Hansson O; Zetterberg H; Podust VN; Davies HA; Waldemar G; Minthon L; Blennow K
    Arch Neurol; 2007 Mar; 64(3):366-70. PubMed ID: 17353378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biomarkers in cerebrospinal fluid and blood in memory complaints].
    Zetterberg H; Andreasen N; Blennow K
    Lakartidningen; 2009 May 13-19; 106(20):1386-9. PubMed ID: 19585836
    [No Abstract]   [Full Text] [Related]  

  • 5. Can CSF measures distinguish among schizophrenia, depression, movement disorders, and dementia?
    Stahl SM
    Psychopharmacol Bull; 1985; 21(3):396-9. PubMed ID: 2863846
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of G-proteins in the molecular diagnosis of psychiatric disorders.
    Schreiber G; Avissar S
    Expert Rev Mol Diagn; 2003 Jan; 3(1):69-80. PubMed ID: 12528365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in geriatric psychiatry.
    Lenze EJ; Mulsant BH
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):827-31. PubMed ID: 17911360
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine metabolites and suicide.
    Sher L
    Nord J Psychiatry; 2007; 61(3):233-4. PubMed ID: 17523037
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of biomarkers in the elderly: current and future challenges.
    Sunderland T; Gur RE; Arnold SE
    Biol Psychiatry; 2005 Aug; 58(4):272-6. PubMed ID: 16018985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid: identification of diagnostic markers for schizophrenia.
    Schwarz E; Bahn S
    Expert Rev Mol Diagn; 2008 Mar; 8(2):209-16. PubMed ID: 18366307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between cerebrospinal fluid biomarkers and depression in elderly women.
    Gudmundsson P; Skoog I; Waern M; Blennow K; Pálsson S; Rosengren L; Gustafson D
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):832-8. PubMed ID: 17911361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Alzheimer's disease.
    Sonnen JA; Keene CD; Montine KS; Li G; Peskind ER; Zhang J; Montine TJ
    Expert Rev Neurother; 2007 Aug; 7(8):1021-8. PubMed ID: 17678497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients.
    Guo J; Sun Z; Xiao S; Liu D; Jin G; Wang E; Zhou J; Zhou J
    Cell Res; 2009 Dec; 19(12):1401-3. PubMed ID: 19949427
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease.
    Skogseth R; Mulugeta E; Jones E; Ballard C; Rongve A; Nore S; Alves G; Aarsland D
    Dement Geriatr Cogn Disord; 2008; 25(6):559-63. PubMed ID: 18536520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usability of cerebrospinal fluid biomarkers in a tertiary memory clinic.
    Brandt C; Bahl JC; Heegaard NH; Waldemar G; Johannsen P
    Dement Geriatr Cogn Disord; 2008; 25(6):553-8. PubMed ID: 18536519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
    Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
    Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
    Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
    Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.
    Simonsen AH; McGuire J; Podust VN; Davies H; Minthon L; Skoog I; Andreasen N; Wallin A; Waldemar G; Blennow K
    Neurobiol Aging; 2008 Jul; 29(7):961-8. PubMed ID: 17321007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans.
    Hartline KM; Owens MJ; Nemeroff CB
    Ann N Y Acad Sci; 1996 Mar; 780():96-105. PubMed ID: 8602742
    [No Abstract]   [Full Text] [Related]  

  • 20. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.
    Shafaati M; Solomon A; Kivipelto M; Björkhem I; Leoni V
    Neurosci Lett; 2007 Sep; 425(2):78-82. PubMed ID: 17822846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.